{
    "Trade/Device Name(s)": [
        "HemoCue Glucose 201 RT system"
    ],
    "Submitter Information": "HemoCue AB",
    "510(k) Number": "K060765",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020935"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFR"
    ],
    "Summary Letter Date": "August 14, 2006",
    "Summary Letter Received Date": "August 14, 2006",
    "Submission Date": "March 17, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "HemoCue Glucose 201 RT Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Modified glucose dehydrogenase method",
        "Photometry"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "In vitro diagnostic"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent",
        "Microcuvette"
    ],
    "Document Summary": "FDA 510(k) summary for HemoCue Glucose 201 RT system for quantitative determination of glucose in whole blood using a portable analyzer and microcuvettes",
    "Indications for Use Summary": "Quantitative determination of glucose in whole blood to supplement clinical evidence for diagnosis and treatment of diabetes; for in vitro diagnostic, professional use only with dedicated microcuvettes",
    "fda_folder": "Clinical Chemistry"
}